TechBio Founders #14 : Transforming human antibodies into drugs with Wyatt McDonnell, CEO Infinimmune

Drugs & Therapeutics

0:00

-1:01:00

TechBio Founders #14 : Transforming human antibodies into drugs with Wyatt McDonnell, CEO Infinimmune

Loretta TIOIELA

Apr 19, 2023

Share

Transcript

Infinimmune’s founding team are tool builders who design from first principles and have broad expertise across immunology, single cell technologies, protein engineering, computational biology, and genome assembly.Transforming human antibodies into drugs.

Discussion about this episode

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Next Sequence®

TechBio Founders #14 : Transforming human antibodies into drugs with Wyatt McDonnell, CEO Infinimmune

Discussion about this episode